查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1890978

神经调控设备市场按设备类型、应用、最终用户和地区划分

Neuromodulation Devices Market, By Device Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，神经调节设备市场规模将达到 187.1 亿美元，到 2032 年将达到 503.8 亿美元，2025 年至 2032 年的复合年增长率为 15.2%。

报告覆盖范围 报告详情
基准年： 2024 2025年市场规模： 187.1亿美元
历史数据时期： 2020年至2024年 预测期： 2025年至2032年
预测期（2025-2032年）复合年增长率： 15.20% 2032 年的预测值： 503.8亿美元

神经调控装置透过电讯号、药物或其他能量形式刺激神经来缓解疼痛，阻断疼痛讯号到达大脑。神经调控装置是植入式医疗设备，透过电刺激和药物传递为某些慢性疾病提供治疗方案。神经调控装置主要分为五个技术领域：脊髓刺激器、深部脑部刺激器、迷走神经刺激器、荐椎神经刺激和胃电刺激器。神经调控装置可向神经和大脑传送电脉衝，用于治疗听力丧失、慢性疼痛和帕金森氏症等疾病。电刺激疗法利用电刺激治疗脊髓损伤和与神经系统疾病相关的肌肉无力。电脉衝被激活并传输到神经调控装置的电极，引起去极化，从而可能缓解疼痛并增强肌肉力量。各种类型的电刺激设备旨在治疗多种疾病，包括疼痛管理和肥胖。

市场动态

预计在预测期内，监管机构对产品核可数量增加将推动全球神经调控设备市场的成长。例如，2023年4月19日，医疗科技公司BIOTRONIK宣布其Prospera脊髓刺激（SCS）系统已获得美国食品药物管理局（FDA）的核准。该系统采用首个多相刺激模式RESONANCE，并结合以患者为中心的Embrace One护理模式，提供自动、客观的日常远端监测、持续管理和支持，从而实现主动式护理。此次核准标誌着该公司新业务部门BIOTRONIK Neuro的推出。

本次调查的主要特点

  • 本报告对全球神经调节设备市场进行了详细分析，以 2024 年为基准年，给出了 2025 年至 2032 年的市场规模和复合年增长率 (%)。
  • 它重点介绍了不同细分市场的潜在商机，并解释了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
  • 该研究根据以下参数对全球神经调控设备市场的主要企业进行了分析——公司亮点、产品系列、关键亮点、财务表现和策略。
  • 本研究涵盖的主要企业包括 Medtronic、BD、LivaNova、Axonics、ShiraTronics、Abbott、Bioventus、Neuronetics、NEVRO CORP、Integer Holdings Corporation、BIOTRONIK、NeuroPace、NeuroMetrix、Helius Medical Technologies 和 Synapse Biomedical Inc.。
  • 本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份关于全球神经调控设备市场的报告将对产业内的各种相关人员有所帮助，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种用于分析全球神经调控设备市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、监管与趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • 市场机会
  • 影响分析
  • 监管指南
  • 产品发布
  • 重大进展
  • PEST分析
  • 波特分析
  • 监管情景
  • 併购
  • 製造商收入
  • 各国卫生支出

4. 2020-2032年全球神经调控设备市场（依设备类型划分）

  • 概述
  • 脊髓刺激装置
  • 深部脑部刺激装置
  • 荐椎神经刺激装置
  • 迷走神经刺激装置
  • 胃电刺激装置

5. 2020-2032年全球神经调控设备市场（依应用领域划分）

  • 概述
  • 疼痛管理
  • 神经系统和运动障碍的治疗
  • 肌肉骨骼疾病管理
  • 代谢和消化器官系统疾病管理
  • 其他（例如，尿失禁管理）

6. 2020-2032年全球神经调控设备市场（依最终用户划分）

  • 概述
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他（理疗中心等）

7. 2020-2032年全球神经调控设备市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东地区
  • 非洲
    • 北非
    • 中非
    • 南非

第八章 竞争情势

  • Medtronic
  • BD
  • LivaNova
  • Axonics, Inc.
  • ShiraTronics
  • Abbott
  • Bioventus
  • Neuronetics
  • NEVRO CORP
  • Integer Holdings Corporation
  • BIOTRONIK
  • NeuroPace, Inc.
  • NeuroMetrix, Inc.
  • Helius Medical Technologies, Inc.
  • Synapse Biomedical Inc.

第九章各节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3861

Neuromodulation Devices Market is estimated to be valued at USD 18.71 Bn in 2025 and is expected to reach USD 50.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.71 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.20% 2032 Value Projection: USD 50.38 Bn

Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.

Key features of the study

  • This report provides an in-depth analysis of the global neuromodulation devices market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
  • The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market

Market Segmentation

  • Global Neuromodulation Devices Market, Device Type
    • Spinal Cord Stimulation Devices
    • Deep Brain Stimulation Devices
    • Sacral Nerve Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Gastric Electric Stimulation Devices
  • Global Neuromodulation Devices Market, Application
    • Pain Management
    • Neurological and Movement Disorder Management
    • Musculoskeletal Disorder Management
    • Metabolism and GIT Management
    • Others (Incontinence Management, etc.)
  • Global Neuromodulation Devices Market, By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialized Clinics
    • Others (Nursing Facilities, etc.)
  • Global Neuromodulation Devices Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Global Neuromodulation Devices Market Companies
    • Medtronic
    • BD
    • LivaNova
    • Axonics, Inc.
    • ShiraTronics
    • Abbott
    • Bioventus
    • Neuronetics
    • NEVRO CORP
    • Integer Holdings Corporation
    • BIOTRONIK
    • NeuroPace, Inc.
    • NeuroMetrix, Inc.
    • Helius Medical Technologies, Inc.
    • Synapse Biomedical Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Device Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Regulatory Guidelines
  • Product launches
  • Key Development
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions
  • Manufacturer Revenue
  • Healthcare Spending by Country

4. Global Neuromodulation Devices Market, By Device Type, 2020-2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Spinal Cord Stimulation Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Deep Brain Stimulation Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Sacral Nerve Stimulation Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Vagus Nerve Stimulation Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Gastric Electric Stimulation Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

5. Global Neuromodulation Devices Market, By Application, 2020-2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Pain Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Neurological and Movement Disorder Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Musculoskeletal Disorder Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Metabolism and GIT Management
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Others (Incontinence Management, etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Neuromodulation Devices Market, By End User, 2020-2032, (US$ Billion)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Specialized Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Others (Physiotherapy Centers, etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Neuromodulation Devices Market, By Region, 2020-2032, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Axonics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ShiraTronics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bioventus
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Neuronetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NEVRO CORP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integer Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BIOTRONIK
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NeuroPace, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NeuroMetrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Helius Medical Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Synapse Biomedical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us